Historical review from 2026-11-19. Current price and availability are unconfirmed; check the original marketplace.
Omnira is a profitable iOS wellness app generating $19.7K monthly revenue with an exceptional 65% profit margin and a 2.67x annual profit multiple—both well below typical SaaS valuation. Verified financials at 22 months of operation and a differentiated 8D Audio Creator feature provide traction in a growing health & fitness category. Key details around customer count, churn, organic acquisition channel durability, and app store performance metrics would help confirm the sustainability of this recurring revenue base.
The core acquisition thesis rests on verified recurring revenue ($19.7K/mo), proven unit economics (65% margins), and an 22-month operating history with an identifiable paid user base—not on the software complexity. A solo founder with AI-assisted coding could build a basic sleep/focus app with audio features, subscription logic, and in-app purchases in 14–18 weeks for $8–18K (Cursor + Claude Pro, Supabase, Stripe, and third-party audio libraries). However, Omnira's real value is its paying customer base, app store presence, retention data, and the 8D Audio Creator as a differentiator—assets that cannot be replicated in weeks. The business is worth buying primarily for traction and distribution, not software novelty. Buyer should prioritize confirming churn and customer concentration before closing, as recurring revenue durability is the primary value driver.
Cash estimate includes the AI tools, APIs and infrastructure needed for a solo founder to recreate the software. Build time is informational and lightly weighted. The verdict is driven mainly by customers, users, verified earnings, retention, distribution, brand, data and operating history.
Omnira is a profitable iOS wellness app for sleep, focus, and relaxation. Its standout 8D Audio Creator transforms music into an immersive listening experience. Users can also create personalized medi
Opens the original listing on TrustMRR
Get new listings with asking prices, monthly profit, deal scores, and key risks.
The best reviewed deals, concise and evidence-first. Unsubscribe anytime.
Preliminary screening based on marketplace and public data. Verify all financial, legal, technical, customer, and operational claims independently before making an acquisition decision. This is not financial or legal advice.